Information about Takim Therapies
My details
*
*
*

Takim Therapies (SPRL)

BE 0892.433.751

Rue Emile Bouilliot 48, 1050 Ixelles

Company information

Status
Active

Enterprise number

BE0892.433.751

VAT liability
Yes
Established
24-09-2007
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Rental and operating of own or leased real estate
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Takim Therapies

2024 2023 2022 2021
Profit/Loss € 8,114 -6 % € 8,602 159 % € 3,319 129 % € -11,299
Equity € -7,361 52 % € -15,475 36 % € -24,077 12 % € -27,396
Gross margin € 8,114 -6 % € 8,602 159 % € 3,319 130 % € -11,146

Publications from Takim Therapies

Date Publication
18-06-2012 Denomination (FR)
05-01-2009 Resignations, Appointments (FR)
09-10-2007 Constitution (FR)

Frequently asked questions

What is the VAT number of Takim Therapies?
The VAT number of Takim Therapies is BE 0892.433.751.
Wat is the PEPPOL ID of Takim Therapies?
There is no information available about the PEPPOL ID of Takim Therapies or the company is not yet registered on the PEPPOL network.
When was Takim Therapies founded?
Takim Therapies was founded on 24-09-2007.
What is the address of Takim Therapies?
The current registered office of Takim Therapies is located at Rue Emile Bouilliot 48, 1050 Ixelles.
When was the last time Takim Therapies filed their annual financial statements?
The most recent financial statements of Takim Therapies were filed on 15-07-2025.
How many employees does Takim Therapies have?
There are currently no employees working at Takim Therapies or no workforce information is available.
What is the annual turnover of Takim Therapies?
At the time of its most recent financial statements, Takim Therapies did not publish any turnover figures. Takim Therapies reported a gross margin of €8,114.04.

Sources